GeneID	MetaboliteID	CandidateAnnotation	SupportingSNPRecords	MinimumP	Scope	ThresholdP	Comparison	GenomeAnnotation
Glyma.03G135200	P00330	2-Aminoflubendazole	2	3.68510626515039e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P01269	Viburtinal	2	1.439812963814e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P17751		2	3.47051647798621e-15	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P19902		2	2.15912228982755e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P20676	3,4,7-Trihydroxy-5-methoxy-8-prenylflavan 4-O-(beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside)	2	2.75500665655543e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P29538	DG(2:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))	2	2.7230466350615e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P31683		2	2.00390436408376e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P32646	Antibiotic DC 11A2	2	2.1510234835978e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P35852		2	8.93125682097665e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P36874		2	4.04939858758256e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P37271	PGP(TXB2/i-15:0)	2	6.78363556009862e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P37350	Nobiloside	2	6.59011894721753e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P37352	16-{[6-O-acetyl-2-O-(6-O-acetyl-beta-D-glucopyranosyl)-beta-D-glucopyranosyl]oxy}hexadecanolide	2	5.84550655747126e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P37460	Consiculine	2	3.00980432509781e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P37611		2	5.71396325659772e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P38229		2	2.39696042116422e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P39997	Avermectin B2b	2	1.27437033150233e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P40157	Cryptoporic acid C	2	5.94004593513201e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P42130	PIP(18:2(10E,12Z)+=O(9)/20:2(11Z,14Z))	2	1.0415457427383e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P44493		2	2.42824901856186e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P44498	PA(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)-OH(19S))	2	6.47864261692874e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P44506		2	8.36035526525163e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P47033	Xenortide A	2	3.3152415880571e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P50584	Caudoxirene	2	8.85152772266374e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P01121	Fuliginosone	1	2.61276557454098e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P03713	Chlordiazepoxide	1	1.06115279134171e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P07452	(+)-Duocarmycin A	1	2.30070684127846e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P10273	5-Imino-2-methyl-1-cyclopenten-1-ol	1	5.59518092371335e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P16555	CD 1790	1	7.33518721065129e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P23185	(E)-3,7-Dimethyl-2,6-octadienyl nonanoate	1	2.28444681072006e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P26792	2-Methoxybenzoic acid	1	2.95519778949239e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P40215	CDP-DG(i-18:0/18:2(9Z,11Z))	1	4.33389014578905e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P42164	Levallorphan	1	9.58175677789805e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P42432	Phthalsaurediethylhexylester	1	7.62394328567818e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P42908		1	9.14828225205434e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P44457	Montanastatin	1	6.43379837946312e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P46667		1	8.46612494623849e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P47300		1	7.11679710136991e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P48287	Hydroxyterbinafine	1	2.02149322916984e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P53012	Cryptophycin 176	1	8.02873545967087e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.03G135200	P53116		1	5.69878063463762e-11	overlap	1e-10	<	Wm82.a2.v1